Biokinetics of ultrafine gold nanoparticles (AuNPs) relating to redistribution and urinary excretion: a long-term in vivo study

References

• Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine. Curr Opin Biotechnol 2007;18:26–30.
   PubMed Web of Science ®Google Scholar
• Pissuwan D, Niidome T, Cortie MB. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 2011;149:65–71.
   PubMed Web of Science ®Google Scholar
• Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev 2012;41:2256–82.
   PubMed Web of Science ®Google Scholar
• Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009;38:1759–82.
   PubMed Web of Science ®Google Scholar
• Sperling RA, Rivera Gil P, Zhang F, et al. Biological applications of gold nanoparticles. Chem Soc Rev 2008;37:1896–908.
   PubMed Web of Science ®Google Scholar
• Prades R, Guerrero S, Araya E, et al. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials 2012;33:7194–205.
   PubMed Web of Science ®Google Scholar
• Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010;62:1064–79.
   PubMed Web of Science ®Google Scholar
• Mackey MA, Ali MRK, Austin LA, et al. The most effective gold nanorod size for plasmonic photothermal therapy: theory and in vitro experiments. J Phys Chem B 2014;118:1319–26.
   PubMed Web of Science ®Google Scholar
• Chandra P, Das D, Wahab AA. Gold nanoparticles in molecular diagnostics and therapeutics. Dig J Nanomed Biostruct 2010;5:363–7.
   Web of Science ®Google Scholar
• Guerrero S, Araya E, Fiedler JL, et al. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. Nanomedicine (Lond) 2010;5:897–913.
   PubMed Web of Science ®Google Scholar
• Chen YH, Tsai CY, Huang PY, et al. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm 2007;4:713–22.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Slatkin N, Focella TM, et al. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006;79:248–53.
   PubMed Web of Science ®Google Scholar
• Bednarski M, Dudek M, Knutelska J, et al. The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: in vivo studies. Pharmacol Rep 2015;67:405–9.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Kim SJ, Kim YH, et al. Susceptibility to gold nanoparticle-induced hepatotoxicity is enhanced in a mouse model of nonalcoholic steatohepatitis. Toxicology 2012;294:27–35.
   PubMed Web of Science ®Google Scholar
• Jenkins JT, Halaney DL, Sokolov KV, et al. Excretion and toxicity of gold–iron nanoparticles. Mater Sci Eng C 2013;33:550–6.
   PubMed Web of Science ®Google Scholar
• Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 2011;40:1647–71.
   PubMed Web of Science ®Google Scholar
• Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 2010;12:2313–33.
   PubMed Web of Science ®Google Scholar
• Almeida JPM, Chen AL, Foster A, et al. In vivo biodistribution of nanoparticles. Nanomedicine (Lond) 2011;6:815–35.
   PubMed Web of Science ®Google Scholar
• Chen YS, Hung YC, Liau I, et al. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett 2009;4:858–64.
   PubMed Web of Science ®Google Scholar
• Su CK, Liu HT, Hsia SC, et al. Quantitatively profiling the dissolution and redistribution of silver nanoparticles in living rats using a knotted reactor-based differentiation scheme. Anal Chem 2014;86:8267–74.
   PubMed Web of Science ®Google Scholar
• Lankveld DPK, Oomen AG, Krystek P, et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010;31:8350–61.
   PubMed Web of Science ®Google Scholar
• Yang RS, Chang LW, Wu JP, et al. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 2007;115:1339–43.
   PubMed Web of Science ®Google Scholar
• Tosa N, Olenic L, Bratu I, et al. Infrared and UV-Vis spectroscopic study of 3,7,10 substituted-phenothiazine derivatives adsorbed on gold nanoparticles. J Phys Conf Ser 2009;182:012019.
   Google Scholar
• Wang Z, Zhang Q, Kuehner D, et al. Green synthesis of 1–2 nm gold nanoparticles stabilized by amine-terminated ionic liquid and their electrocatalytic activity in oxygen reduction. Green Chem 2008;10:907–9.
   Web of Science ®Google Scholar
• Fraga S, Brandão A, Soares MA, et al. Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. Nanomed Nanotechnol Biol Med 2014;10:1757–66.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Wu HY, Wu D, et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomedicine 2010;5:771–81.
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 2010;245:116–23.
   PubMed Web of Science ®Google Scholar
• Kumar M, Singh G, Arora V, et al. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. Int J Nanomedicine 2012;7:3503–16.
   PubMed Web of Science ®Google Scholar
• Bac LH, Kim JS, Kim JC. Size, optical, and stability properties of gold nanoparticles synthesized by electrical explosion of wire in different aqueous. Rev Adv Mater Sci 2011;28:117–12.
   Web of Science ®Google Scholar
• Clogston JD, Patri AK. Zeta potential measurement. Methods Mol Biol 2011;697:63–70.
   PubMedGoogle Scholar
• Quang LL, Thi PLD, Huynh PUN, et al. Biodistribution of gold nanoparticles synthesized by γ-irradiation after intravenous administration in mice. Adv Nat Sci Nanosci Nanotechnol 2014;5:025009.
   Google Scholar
• Balasubramanian SK, Jittiwat J, Manikandan J, et al. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 2010;31:2034–204.
   PubMed Web of Science ®Google Scholar
• Mi-Rae J, Song-Hwa B, Mi-Ran G, et al. Toxicity and biokinetics of colloidal gold nanoparticles. Nanomaterials 2015;5:835–50.
   Web of Science ®Google Scholar
• Zhang J, Nie X, Ji Y, et al. Quantitative biokinetics and systemic translocation of various gold nanostructures are highly dependent on their size and shape. J Nanosci Nanotechnol 2014;14:4124–38.
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 2008;66:274–80.
   PubMed Web of Science ®Google Scholar
• Langrish JP, Miller M, Raftis J, et al. Translocation and accumulation of inhaled gold nanoparticles in atherosclerotic plaque. J Am Coll Cardiol 2014;63: doi:10.1016/S0735-1097(14)62120-3.
   Web of Science ®Google Scholar
• Simpson CA, Salleng KJ, Cliffel DE, et al. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomed Nanotechnol Biol Med 2013;9:257–63.
   PubMed Web of Science ®Google Scholar
• Hirn S, Semmler-Behnke M, Schleh C, et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 2011;77:407–16.
   PubMed Web of Science ®Google Scholar
• Moller W, Felten K, Sommerer K, et al. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med 2008;177:426–32.
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 2010;393:649–55.
   PubMed Web of Science ®Google Scholar
• Wojnicki M, Luty-Blocho M, Bednarski M, et al. Tissue distribution of gold nanoparticles after single intravenous administration in mice. Pharmacol Rep 2013;65:1033–8.
   PubMed Web of Science ®Google Scholar
• Semmler-Behnke M, Kreyling WG, Lipka J, et al. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008;4:2108–11.
   PubMed Web of Science ®Google Scholar
• Marek W, Magdalena LB, Marek B, et al. Tissue distribution of gold nanoparticles after single intravenous administration in mice. Pharm Rep 2013;65:1033–8.
   PubMed Web of Science ®Google Scholar
• Morais T, Soares ME, Duarte JA, et al. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat. Eur J Pharm Biopharm 2012;80:185–93.
   PubMed Web of Science ®Google Scholar
• Sadauskas E, Danscher G, Stoltenberg M, et al. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 2009;5:162–9.
   PubMed Web of Science ®Google Scholar
• Payne BJ, Saunders LZ. Heavy metal nephropathy of rodents. Vet Pathol Suppl 1978;15:51–87.
   PubMedGoogle Scholar
• Shiro U. Nephrotoxicity of gold salts, D-penicillamine, and allopurinol. In: Clinical nephrotoxins. Netherlands: Springer; 1998:223–38.
   Google Scholar
• Longmire M, Choyke PL, Kobayashi H. Clearance properties of nanosized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 2008;3:703–17.
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotechnol 2007;25:1165–70.
   PubMed Web of Science ®Google Scholar
• Cho M, Cho WS, Choi M, et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 2009;189:177–83.
   PubMed Web of Science ®Google Scholar